TScan Therapeutics
TCRX
#9270
Rank
NZ$0.12 B
Marketcap
$2.22
Share price
-1.19%
Change (1 day)
-81.86%
Change (1 year)

EPS for TScan Therapeutics (TCRX)

EPS in 2023 (TTM): -$4.72

According to TScan Therapeutics's latest financial reports the company's current EPS (TTM) is -$5.15. In 2022 the company made an earnings per share (EPS) of -$4.90 a decrease over its 2021 EPS that were of -$3.88.

EPS history for TScan Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.72-3.63%
2022-$4.9026.25%
2021-$3.8899.58%
2020-$1.94